Structural lung damage after chemotherapy. Fact or fiction?

Lung Cancer

Volumn 67, Issue 3, 2010, Pages 306-310

  Leo, Francesco ^a   Pelosi, Giuseppe ^a,b   Sonzogni, Angelica ^a   Chilosi, Marco ^c   Bonomo, Guido ^a   Spaggiari, Lorenzo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Chemotherapy; Dlco; Lung toxicity; Pneumonectomy

Indexed keywords

CARBON MONOXIDE; CISPLATIN; GEMCITABINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CANCER CHEMOTHERAPY; CANCER SURGERY; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG DIFFUSION; LUNG INJURY; LUNG PARENCHYMA; LUNG RESECTION; MALE; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG; LUNG INJURY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PNEUMONIA; PREOPERATIVE PERIOD;

EID: 75749111633     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.04.013     Document Type: Article

References (16)

1. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung carcinoma. Ann Thorac Surg 72 (2001) 885-888
2. Novoa N., Varela G., and Jimenez M.F. Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy. Eur J Cardiothorac Surg 20 (2001) 700-704
3. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risk of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
4. Leo F., Solli P., Veronesi G., Radice D., Floridi A., Gasparri R., et al. Does chemotherapy increase the risk of respiratory complications after pneumonectomy?. J Thorac Cardiovasc Surg 132 (2006) 519-523
5. Kudoh S., Kato H., Nishiwaki Y., Fukuoka M., Nakata K., Ichinose Y., et al. Interstitial lung disease in Japanese lung cancer patients. A cohort and nested case-control study. Am J Respir Crit Care Med 177 (2008) 1348-1357
6. Bhalla K.S., Wilczynski S.W., Abushamaa A.M., Petros W.P., McDonald C.S., Loftis J.S., et al. Pulmonary toxicity of induction chemotherapy prio to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med 161 (2000) 17-25
7. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopatic interstitial pneumonias. Am J Respir Crit Care Med 165 (2002) 277-304
8. Liebow A. Definition and classification of interstitial pneumonias in humans pathology. Prog Respir Res 8 (1975) 1-33
9. Maas K.W., van der Lee I., Bolt K., Zanen P., Lammers J.W.J., and Schramel F.M.N.H. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. Lung Cancer 41 (2003) 345-351
10. Leo F., Solli P., Spaggiari L., Veronesi G., de Braud F., Leon M.E., et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?. Ann Thorac Surg 77 (2004) 260-265
11. Takeda S., Funakoshi Y., Kadota Y., Koma M., Maeda H., Kawamura S., et al. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?. Ann Thorac Surg 82 (2006) 232-236
12. Dimopoulou I., Efstathiou E., Samakovli, Dafni U., Moulopoulos L.A., Papadimitriou C., et al. A prospective study on lung toxicity in atients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment. Ann Oncol 15 (2004) 1250-1255
13. Videtic G.H., Stitt L.W., Ash R.B., Truong P.T., Dar A.R., Yu E.W., et al. Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. Lung Cancer 43 (2004) 159-166
14. Taghian A.G., Assaad S.I., Niemierko A., Kuter I., Younger S., Schoenthaler R., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. JNCI 93 (2001) 1806-1811
15. Endo S., Sato Y., Hasegawa T., Tetsuka K., Otani S., Saito N., et al. Preoperative chemotherapy increases cytokine production after lung cancer surgery. Eur J Cardiothorac Surg 26 (2004) 787-791
16. Ardizzoia A., Lissoni P., Tancini G., Paolorossi F., Crispino S., Villa S., et al. Respiratory distress syndrome in patients with advanced cancer treated with pentoxyphylline: a randomized study. Support Care Cancer 1 (1993) 331-333